ABSTRACT NUMBER: ESOC2026LB196 INTRA-ARTERIAL ALLOGENIC MESENCHYMAL STEM CELLS (NCS-01) FOLLOWING THROMBECTOMY: PHASE 1 SAFETY, FEASIBILITY, AND EXPLORATORY EFFICACY SIGNALS

Dileep Yavagal, Minako Koga, Aaron Rodriguez Calienes, Jason Tarpley, Parita Bhuva, Brian Snelling, Dennis Rivet, Sean Savitz · 2026

Read ABSTRACT NUMBER: ESOC2026LB196 INTRA-ARTERIAL ALLOGENIC MESENCHYMAL STEM CELLS (NCS-01) FOLLOWING THROMBECTOMY: PHASE 1 SAFETY, FEASIBILITY, AND EXPLORATORY EFFICACY SIGNALS by Dileep Yavagal, Minako Koga, Aaron Rodriguez Calienes, Jason Tarpley, Parita Bhuva, Brian Snelling, Dennis Rivet, Sean Savitz (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13144925.txt.

Description

Dileep Yavagal and co-authors report a phase 1 trial of stem cells given after thrombectomy for acute ischaemic stroke. Their 2026 abstract notes that many treated patients are still left disabled, so new ways to aid recovery are needed.

The cells, called NCS-01, are an allogeneic mesenchymal stem cell product made from bone marrow. They were given by an intra-arterial route after successful thrombectomy to patients with anterior circulation stroke. Two small dose groups were randomized against a sham treatment, with higher cell doses in the second group. The main aims were safety and feasibility, with early signs of benefit also explored.

Catalog record

CREATORDileep Yavagal, Minako Koga, Aaron Rodriguez Calienes, Jason Tarpley, Parita Bhuva, Brian Snelling, Dennis Rivet, Sean Savitz
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13144925

Browse the full library · About the Tower of Babel